Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinpei Imori

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Entropy (Basel, Switzerland)|December 3, 2020
An Information Criterion for Auxiliary Variable Selection in Incomplete Data AnalysisShinpei Imori, Hidetoshi Shimodaira
Asian Pacific Journal of Cancer Prevention : APJCP|October 28, 2025
Quantifying the Contribution of Viral Hepatitis Control Policies and Improvement of Hepatitis C Treatment in Japan during 2000-2030 based on Simulation ModellingTomoyuki Akita, Junko Tanaka, Shinpei Imori, et al.
Japanese Journal of Clinical Oncology|March 20, 2019
Statistical inference for estimating the incidence of cancer at the prefectural level in JapanRyunosuke Tanabe, Ken-Ichi Kamo, Keisuke Fukui, et al.
BMC Oral Health|May 2, 2024
Efficacy of Episil® in patients with hematologic malignancies: a comparative studyTaeko Fukutani, Yukio Yoshioka, Shinpei Imori, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Entropy (Basel, Switzerland)|December 3, 2020
An Information Criterion for Auxiliary Variable Selection in Incomplete Data AnalysisShinpei Imori, Hidetoshi Shimodaira
Asian Pacific Journal of Cancer Prevention : APJCP|October 28, 2025
Quantifying the Contribution of Viral Hepatitis Control Policies and Improvement of Hepatitis C Treatment in Japan during 2000-2030 based on Simulation ModellingTomoyuki Akita, Junko Tanaka, Shinpei Imori, et al.
Japanese Journal of Clinical Oncology|March 20, 2019
Statistical inference for estimating the incidence of cancer at the prefectural level in JapanRyunosuke Tanabe, Ken-Ichi Kamo, Keisuke Fukui, et al.
BMC Oral Health|May 2, 2024
Efficacy of Episil® in patients with hematologic malignancies: a comparative studyTaeko Fukutani, Yukio Yoshioka, Shinpei Imori, et al.
Pageof 1